REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharmaplus Latoszek sp. j. (Poland)

Main Activities: Department Stores
Full name: Pharmaplus Latoszek sp. j. Profile Updated: October 07, 2022
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Pharmaplus Latoszek sp. j. is a company in Poland, with a head office in Brwinow. The company operates in the Department Stores industry. It was incorporated on February 17, 2017. The latest financial highlights indicate a net sales revenue increase of 13.88% in 2022. Its’ total assets recorded a growth of 8.03%. The net profit margin of Pharmaplus Latoszek sp. j. decreased by 1.44% in 2022.

Headquarters
Ul. Fryderyka Chopina 39
Brwinow; Mazowieckie; Postal Code: 05-840

Contact Details: Purchase the Pharmaplus Latoszek sp. j. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Pharmaplus Latoszek sp. j. report to view the information.
Incorporation Date:
February 17, 2017
Key Executives
Purchase this report to view the information.
Associate
Purchase this report to view the information.
Associate
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Pharmaplus Latoszek sp. j. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
13.88%
Total operating revenue
11.99%
Operating profit (EBIT)
-1.76%
EBITDA
-1.75%
Net Profit (Loss) for the Period
-1.58%
Total assets
8.03%
Total equity
8.98%
Operating Profit Margin (ROS)
-1.46%
Net Profit Margin
-1.44%
Return on Equity (ROE)
-5.49%
Debt to Equity Ratio
-5.2%
Quick Ratio
-0.05%
Cash Ratio
-0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?